SCHEMBL14647226

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

	Compound	similarity	top predicted	shared targets
	SCHEMBL14647183	0.91	PARP1 (0.46)	TSHRPARP1
	SCHEMBL14647223	0.91	SIGMAR1 (0.45)	KMT2ATSHRPARP1
	SCHEMBL14647220	0.90	TP53 (0.47)	TNKSPARP1
	SCHEMBL14647189	0.87	PARP1 (0.43)	PARP1
	SCHEMBL14647194	0.87	PARP1 (0.47)	PARP1
	SCHEMBL14647166	0.87	PARP1 (0.49)	HTR1APARP1
	SCHEMBL14647225	0.86	PARP1 (0.48)	TNKSPARP1
	SCHEMBL14647155	0.86	—	—
	SCHEMBL14647187	0.85	DRD4 (0.43)	MEN1KMT2ATSHRHTR1APARP1
	SCHEMBL15979574	0.85	PARP1 (0.49)	TNKSHTR1APARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.